EDWARDS LIFESCIENCES CORPORATION (EW) FY2025 Q1 Statement of Cash Flows

Statement of Cash Flows

2025-01-01 to 2025-03-31

Swipe to see the full flow
EDWARDS LIFESCIENCES CORPORATION cash flow reconciliation, Jan 1, 2025 through Mar 31, 2025One connected Sankey reconciles operating, investing and financing net cash flows through a shared cash pool, from beginning cash to ending cash. Ribbons flow left to right on one dollar scale. Activity totals are dark gray; beginning and ending cash are blue. Cash basis for beginning and ending balances and net cash change: Cash, cash equivalents, and restricted cash. Intermediate calculation bars are lighter gray. Net income is green for profit and red for loss. Identified asset purchases, sales and maturities are blue in either cash direction. Purple identifies capital transactions such as borrowing, repayments, share issuance and dividends. Free cash flow is a separate comparison, not an added cash flow. Read chart description and values below for full signed amounts, including zero items.Net income → Net cash from operating activities: $280,400,000.00Net income → Operating adjustments reconciliation: $76,000,000.00Income taxes → Operating adjustments reconciliation: $51,200,000.00Stock-based compensation → Operating adjustments reconciliation: $40,200,000.00Depreciation and amortization → Operating adjustments reconciliation: $36,600,000.00Loss (gain) on investments, net → Operating adjustments reconciliation: $12,500,000.00Prepaid expenses and other current assets → Operating adjustments reconciliation: $10,600,000.00Non-cash operating lease cost → Operating adjustments reconciliation: $6,100,000.00Other → Operating adjustments reconciliation: $3,600,000.00Operating adjustments reconciliation → Accounts payable and accrued liabilities: $103,400,000.00Operating adjustments reconciliation → Accounts and other receivables, net: $43,700,000.00Operating adjustments reconciliation → Intellectual property agreement accrual: $36,700,000.00Operating adjustments reconciliation → Other: $28,600,000.00Operating adjustments reconciliation → Deferred income taxes: $24,300,000.00Operating adjustments reconciliation → Inventories: $100,000.00Proceeds from available-for-sale investments (Note 5) → investing reconciliation: $827,900,000.00Proceeds from held-to-maturity investments (Note 5) → investing reconciliation: $17,700,000.00Other → investing reconciliation: $100,000.00investing reconciliation → Net cash from investing activities: $85,300,000.00investing reconciliation → Purchases of available-for-sale investments (Note 5): $634,500,000.00investing reconciliation → Capital expenditures: $56,000,000.00investing reconciliation → Payment for working capital adjustment for sale of product group (Note 4): $36,300,000.00investing reconciliation → Issuances of notes receivable: $17,800,000.00investing reconciliation → Purchases of held-to-maturity investments (Note 5): $12,800,000.00investing reconciliation → Payment for acquisition options: $3,000,000.00Net cash used in financing activities → financing reconciliation: $258,000,000.00Proceeds from stock plans → financing reconciliation: $49,900,000.00Other → financing reconciliation: $700,000.00financing reconciliation → Purchases of treasury stock: $258,600,000.00financing reconciliation → Equity forward contract related to accelerated share repurchase agreement (Note 10): $50,000,000.00Beginning cash: Cash, cash equivalents, and restricted cash → Cash sources and uses: $3,058,800,000.00Net cash from operating activities → Cash sources and uses: $280,400,000.00Net cash from investing activities → Cash sources and uses: $85,300,000.00Cash sources and uses → Exchange-rate effect: $17,700,000.00Cash sources and uses → Ending cash: Cash, cash equivalents, and restricted cash: $3,148,800,000.00Cash sources and uses → Net cash used in financing activities: $258,000,000.00Deferred income taxes: -$24,300,000.00Deferred tax balances−$24.30 MInventories: -$100,000.00Inventories−$100.00 KIntellectual property agreement accrual: -$36,700,000.00Intellectual property accrual−$36.70 MNon-cash operating lease cost: $6,100,000.00Operating lease amortization+$6.10 MStock-based compensation: $40,200,000.00Stock-based compensation+$40.20 MNet income: $356,400,000.00Net income+$356.40 MDepreciation and amortization: $36,600,000.00Depreciation & amortization+$36.60 MAccounts and other receivables, net: -$43,700,000.00Accounts & other receivables−$43.70 MIncome taxes: $51,200,000.00Income taxes payable+$51.20 MOther: -$28,600,000.00Other working capital, net−$28.60 MPrepaid expenses and other current assets: $10,600,000.00Prepaid & other assets+$10.60 MAccounts payable and accrued liabilities: -$103,400,000.00Payables & accrued liabilities−$103.40 MOther: $3,600,000.00Other non-cash items+$3.60 MLoss (gain) on investments, net: $12,500,000.00Investment gain & loss+$12.50 MNet cash from operating activities: $280,400,000.00Operating cash+$280.40 MOperating adjustments reconciliation: $236,800,000.00Other: $700,000.00Other financing, net+$700.00 KProceeds from stock plans: $49,900,000.00Stock plan proceeds+$49.90 MPurchases of treasury stock: -$258,600,000.00Common stock repurchases−$258.60 MEquity forward contract related to accelerated share repurchase agreement (Note 10): -$50,000,000.00Accelerated repurchase forward−$50.00 MNet cash used in financing activities: -$258,000,000.00. Cash required to fund net payments.Financing cash−$258.00 Mfinancing reconciliation: $308,600,000.00Capital expenditures: -$56,000,000.00PP&E purchases−$56.00 MPayment for acquisition options: -$3,000,000.00Payment for acquisition options−$3.00 MInvestments in intangible assets: $0.00Proceeds from available-for-sale investments (Note 5): $827,900,000.00AFS securities proceeds+$827.90 MOther: $100,000.00Other investing, net+$100.00 KIssuances of notes receivable: -$17,800,000.00Issuances of notes receivable−$17.80 MProceeds from held-to-maturity investments (Note 5): $17,700,000.00HTM sales & maturities+$17.70 MPurchases of available-for-sale investments (Note 5): -$634,500,000.00AFS securities purchases−$634.50 MPurchases of held-to-maturity investments (Note 5): -$12,800,000.00HTM securities purchases−$12.80 MPayment for working capital adjustment for sale of product group (Note 4): -$36,300,000.00Working capital adjustment paid−$36.30 MNet cash from investing activities: $85,300,000.00Investing cash+$85.30 Minvesting reconciliation: $845,700,000.00Cash sources and uses: $3,424,500,000.00Beginning cash: Cash, cash equivalents, and restricted cash: $3,058,800,000.00Beginning cash$3.06 BEnding cash: Cash, cash equivalents, and restricted cash: $3,148,800,000.00Ending cash$3.15 BExchange-rate effect: -$17,700,000.00FX effect−$17.70 MCASH RECONCILIATIONOperatingflowsInvestingflowsFinancingflowsFree cash flow$224.40 MOperating cash − cash spent on PP&ECash flow / Net income0.79×Operating cash flow ÷ net incomeNet cash change+$90.00 MEnding cash − beginning cash
Chart details

EDWARDS LIFESCIENCES CORPORATION cash flow reconciliation, Jan 1, 2025 through Mar 31, 2025

Cash flows for Jan 1, 2025 through Mar 31, 2025. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Dec 31, 2024. Ending cash: Mar 31, 2025. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

Beginning cash on Dec 31, 2024
3,058,800,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
Operating activities
280,400,000 US dollars. Net cash provided.
Deferred income taxes
negative 24,300,000 US dollars
Inventories
negative 100,000 US dollars
Intellectual property agreement accrual
negative 36,700,000 US dollars
Non-cash operating lease cost
6,100,000 US dollars
Stock-based compensation
40,200,000 US dollars
Net income
356,400,000 US dollars
Depreciation and amortization
36,600,000 US dollars
Accounts and other receivables, net
negative 43,700,000 US dollars
Income taxes
51,200,000 US dollars
Other
negative 28,600,000 US dollars
Prepaid expenses and other current assets
10,600,000 US dollars
Accounts payable and accrued liabilities
negative 103,400,000 US dollars
Other
3,600,000 US dollars
Loss (gain) on investments, net
12,500,000 US dollars
Investing activities
85,300,000 US dollars. Net cash provided.
Capital expenditures
negative 56,000,000 US dollars
Payment for acquisition options
negative 3,000,000 US dollars
Investments in intangible assets
0 US dollars
Proceeds from available-for-sale investments (Note 5)
827,900,000 US dollars
Other
100,000 US dollars
Issuances of notes receivable
negative 17,800,000 US dollars
Proceeds from held-to-maturity investments (Note 5)
17,700,000 US dollars
Purchases of available-for-sale investments (Note 5)
negative 634,500,000 US dollars
Purchases of held-to-maturity investments (Note 5)
negative 12,800,000 US dollars
Payment for working capital adjustment for sale of product group (Note 4)
negative 36,300,000 US dollars
Financing activities
negative 258,000,000 US dollars. Net cash used.
Other
700,000 US dollars
Proceeds from stock plans
49,900,000 US dollars
Purchases of treasury stock
negative 258,600,000 US dollars
Equity forward contract related to accelerated share repurchase agreement (Note 10)
negative 50,000,000 US dollars
Operating adjustment reconciliation
236,800,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
financing gross reconciliation
308,600,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
investing gross reconciliation
845,700,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
Exchange-rate effect
negative 17,700,000 US dollars
Ending cash on Mar 31, 2025
3,148,800,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
Cash sources and uses
3,424,500,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
Net cash change
90,000,000 US dollars. Ending cash minus beginning cash.
Cash flow / Net income
0.79×. Operating cash flow divided by reconciliation net income for the same period. Black from 0.90× through 1.10×; green above 1.10×; red below 0.90×. Color uses the unrounded ratio.
Operating cash flow
280,400,000 US dollars. Operating cash flow used in the free cash flow calculation.
Cash purchases of property, plant and equipment
56,000,000 US dollars. These cash purchases are already included in investing activities above.
Free cash flow
224,400,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.

Chart connections

  • Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
  • Financing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Investing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Operating reconciliation adjustments are not all independent cash receipts.
  • Net income exceeds operating cash. The diagram allocates $280.40M of net income directly to operating cash and $76.00M to the adjustment junction, where it combines with other additions to reconcile deductions. This is an accounting presentation, not a tracing of cash receipts.
  • Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
  • The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
  • Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: 280,400,000 US dollars minus 56,000,000 US dollars equals 224,400,000 US dollars.
EDWARDS LIFESCIENCES CORPORATION (EW) FY2025 Q1 Statement of Cash Flows Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!